SCHEMBL7716799

SCHEMBL7716799

Cc1c(O)cccc1CC#N

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.45
ATM Q13315 1/20 0.45
HPGD P15428 2/20 0.38
ENPP2 Q13822 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 2/20 0.38
TP53 P04637 1/20 0.38
GAA P10253 1/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
HSPA5 P11021 1/20 0.37
PDCD1 Q15116 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
MMP3 P08254 1/20 0.36
GABRA1 P14867 1/20 0.35
GABRB2 P47870 1/20 0.35
HTR1A P08908 1/20 0.34
IAPP P10997 1/20 0.34
AR P10275 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31186853 1.00 TRPA1 (0.45) TRPA1ATMHPGDENPP2ALDH1A1
SCHEMBL28380698 0.87 ALDH1A1 (0.45) HPGDENPP2ALDH1A1MAPTPDCD1
SCHEMBL957760 0.82 AR (0.41) TRPA1ATMHPGDENPP2ALDH1A1
SCHEMBL28909080 0.79 ALDH1A1 (0.46) TRPA1HPGDENPP2ALDH1A1MAPT
SCHEMBL3792645 0.79 ESR1 (0.41) TRPA1ATMHPGDENPP2ALDH1A1
SCHEMBL891289 0.79 HSPA5 (0.54) HPGDALDH1A1MAPTHSD17B10HSPA5
SCHEMBL845508 0.76 HSPA5 (0.56) TRPA1ATMHPGDALDH1A1MAPT
SCHEMBL3072494 0.76 ALDH1A1 (0.50) TRPA1ATMHPGDALDH1A1HSD17B10
SCHEMBL23210828 0.76 ALDH1A1 (0.38) HPGDENPP2ALDH1A1PDCD1CD274
SCHEMBL3933757 0.76 TSHR (0.43) ATMHPGDENPP2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101723999-B Method for total synthesis of icariin compounds SHANGHAI SIJIYA PHARMACEUTICAL TECHNOLOGY CO LTD 2012-05-09 CN disclosed
CN-101723999-A Method for synthesizing epimedium herb glycosides SHANGHAI SIJIYA PHARMACEUTICAL 2010-06-09 CN disclosed
US-6376512-B1 FOR TREATING PHYSIOLOGICAL CONDITION IN PATIENT WHEREIN SAID CONDITION IS ASSOCIATED WITH A PHYSIOLOGICALLY DETRIMENTAL LEVELS OF INSULIN, GLUCOSE, FREE FATTY ACIDS, OR TRIGLYCERIDES AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-04-23 US disclosed
US-5059610-A QUINOLINE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF LEUKOTRIENE D4 RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1991-10-22 US disclosed
US-4920132-A Quinoline derivatives and use thereof as antagonists of leukotriene D4 RORER PHARMACEUTICAL CORP. (US) 1990-04-24 US disclosed